History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention

Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants

(2016) Stan L. Block et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Changes in the Population Structure of InvasiveNeisseria meningitidisin the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure

(2015) Xin Wang et al.   JOURNAL OF INFECTIOUS DISEASES

First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak

(2015) L. A. McNamara et al.   PEDIATRICS

Epidemiology of Infant Meningococcal Disease in the United States, 2006-2012

(2015) J. R. MacNeil et al.   PEDIATRICS

A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial

(2015) Stan L. Block et al.   VACCINE

Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015

(2015) Jessica R. MacNeil et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Elevated Risk for Invasive Meningococcal Disease Among Persons With HIV

(2013) Laura Miller et al.   ANNALS OF INTERNAL MEDICINE

Prolonged University Outbreak of Meningococcal Disease Associated With a Serogroup B Strain Rarely Seen in the United States

(2013) Sema Mandal et al.   CLINICAL INFECTIOUS DISEASES

Seroprevalence and Placental Transmission of Maternal Antibodies Specific for Neisseria meningitidis Serogroups A, C, Y and W135 and Influence of Maternal Antibodies on the Immune Response to a Primary Course of MenACWY-CRM Vaccine in the United Kingdom

(2013) Geraldine Blanchard-Rohner et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age

(2013) Terry M Nolan et al.   Human Vaccines & Immunotherapeutics

Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age

(2013) S. A. Halperin et al.   Journal of the Pediatric Infectious Diseases Society

Meningococcal disease: Clinical presentation and sequelae

(2012) David Pace et al.   VACCINE

The changing epidemiology of meningococcal disease in North America 1945–2010

(2012) Carmen Baccarini et al.   Human Vaccines & Immunotherapeutics

The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease

(2011) Lee H. Harrison et al.   VACCINE

Immunogenicity and Safety of a Multicomponent Meningococcal Serogroup B Vaccine and a Quadrivalent Meningococcal CRM197Conjugate Vaccine against Serogroups A, C, W-135, and Y in Adults Who Are at Increased Risk for Occupational Exposure to Meningococcal Isolates

(2010) Alan Kimura et al.   Clinical and Vaccine Immunology

Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity

(2010) H. Campbell et al.   Clinical and Vaccine Immunology

Epidemiology and Meningococcal Serogroup Distribution in the United States

(2010) Jody H. Hershey et al.   CLINICAL PEDIATRICS

Meningococcal carriage by age: a systematic review and meta-analysis

(2010) Hannah Christensen et al.   LANCET INFECTIOUS DISEASES

Phase I/II, Open-Label Trial of Safety and Immunogenicity of Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Human Immunodeficiency Virus-Infected Adolescents

(2010) George K. Siberry et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents

(2009) Lisa A. Jackson et al.   CLINICAL INFECTIOUS DISEASES

Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease

(2009) Amanda C. Cohn et al.   CLINICAL INFECTIOUS DISEASES

MCV vaccination in the presence of vaccine-associated Guillain–Barré Syndrome risk: A decision analysis approach

(2009) Bo-Hyun Cho et al.   VACCINE